Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
ACP3 encodes an enzyme that catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. De plus, nous expédions Acid Phosphatase 3 Kits (27) et Acid Phosphatase 3 Protéines (4) et beaucoup plus de produits pour cette protéine.
Showing 5 out of 5 products:
Enhanced TDPase and TMPase (Montrer ACPP Anticorps) activities may contribute to the reduction of TDP level in AD patients. The results imply that an imbalance of phosphorylation-dephosphorylation related to thiamine and glucose metabolism may be a potential target for AD prevention and therapy.
Thirteen single nucleotide polymorphism (SNPs) in acid phosphatase prostate (ACPP (Montrer ACPP Anticorps)) were suggested as candidate causal alleles that underlie ACPP (Montrer ACPP Anticorps) regulation and expression.
we have measured the intramolecular diffusion of the full length and 8-residue deletion peptides at two different pHs (Montrer PCBD1 Anticorps) and found a correlation with fibrillization lag (Montrer STMN1 Anticorps) time. These results can be explained by a simple kinetic model of the early stages of aggregation in which oligomerization is controlled by the rate of peptide reconfiguration.
Prostatic acid phosphatase (Montrer ACPP Anticorps) delays prostate cancer cell growth in G1 phase of the cell cycle.
Studies suggest that understanding of prostatic acid phosphatase (Montrer ACPP Anticorps) function and regulation of expression will have a significant impact on understanding prostate cancer (PCa (Montrer FLVCR1 Anticorps)) progression and therapy.
Certain factors identified within semen, termed semen-derived enhancers of virus infection (SEVI), fragments of prostatic acid phosphatase (Montrer ACPP Anticorps), have been shown to significantly enhance HIV-1 infectivity.
ACPP (Montrer ACPP Anticorps) increases significantly in epithelial cells of ovarian carcinoma, which indicates that it may be a candidate biomarker for diagnosis of epithelia-derived ovarian cancer in women.
Data indicate that hypoxia regulates prostatic acid phosphatase (PAP (Montrer ACPP Anticorps)) through hypoxia-inducible factor 2 alpha (Montrer EPAS1 Anticorps) (HIF2alpha (Montrer EPAS1 Anticorps)) and from stimulated A2B (Montrer ADORA2B Anticorps) adenosine receptors.
GCNT1 (Montrer GCNT1 Anticorps) is over-expressed in prostate cancer and is associated with higher levels of core 2 O-sLe(x) in PSA (Montrer PLAG1 Anticorps), PAP (Montrer REG3A Anticorps) and MUC1 (Montrer MUC1 Anticorps) proteins.
Data indicate that prostate acid phosphatase-based peptide vaccine PAP (Montrer REG3A Anticorps)-114-128 peptide appears to be a relevant for the treatment of prostate cancer.
This gene encodes an enzyme that catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is synthesized under androgen regulation and is secreted by the epithelial cells of the prostate gland. An alternatively spliced transcript variant encoding a longer isoform has been found for this gene. This isoform contains a transmembrane domain and is localized in the plasma membrane-endosomal-lysosomal pathway.
, prostatic acid phosphatase
, prostatic acid phosphotase
, thiamine monophosphatase